S'abonner

Demographic and clinical correlates of acute and convalescent SARS-CoV-2 infection among patients of a U.S. emergency department - 09/10/21

Doi : 10.1016/j.ajem.2021.04.081 
Oliver Laeyendecker, PhD, MBA a, b, c, 1, , Yu-Hsiang Hsieh, PhD d, 1, Richard E. Rothman, MD, PhD d, Gaby Dashler, BS d, Thomas Kickler, MD e, Reinaldo E. Fernandez, BS b, William Clarke, PhD e, Eshan U. Patel, MPH c, e, Aaron A.R. Tobian, MD, PhD e, Gabor D. Kelen, MD d, Thomas C. Quinn, MD, MSc a, b, c

Johns Hopkins COVID-19 EM Investigators

Haley A. Schmidt 1, Jernelle Miller 2, Morgan Keruly 3, Ethan Klock 2, Charles S. Kirby 1, Owen R. Baker 3, Richard Wang 4, Isabel V. Lake 4, Mehdi Youbi 4, Sarah Reineck 4, Momina Khan 4, Ross Knaub 4, Erin Ricketts 4, Yolanda J. Eby 1, Danna Anderson 1, Jennifer Hurley 1
1 Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America 
2 Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America 
3 Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Baltimore, MD, United States of America 
4 Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America 

a Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Baltimore, MD, United States of America 
b Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America 
c Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States of America 
d Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America 
e Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America 

Corresponding author at: 855 North Wolfe St. Rangos Building, room 538A, Baltimore, MD 21205, United States of America.855 North Wolfe St. Rangos Buildingroom 538ABaltimoreMD21205United States of America

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Abstract

Background

Emergency Departments (EDs) have served as critical surveillance sites for infectious diseases. We sought to determine the prevalence and temporal trends of acute (by PCR) and convalescent (by antibody [Ab]) SARS-CoV-2 infection during the earliest phase of the pandemic among patients in an urban ED in Baltimore City.

Methods

We tested remnant blood samples from 3255 unique ED patients, collected between March 16th and May 31st 2020 for SARS-CoV-2 Ab. PCR for acute SARS-CoV-2 infection from nasopharyngeal swabs was obtained on any patients based on clinical suspicion. Hospital records were abstracted and factors associated with SARS-CoV-2 infection were assessed.

Results

Of 3255 ED patients, 8.2% (95%CI: 7.3%, 9.2%) individuals had evidence of SARS-CoV-2 infection; 155 PCR+, 78 Ab+, and 35 who were both PCR+ and Ab+. Prevalence of disease increased throughout the study period, ranging from 3.2% (95%CI: 1.8%, 5.2%) PCR+ and 0.6% (95%CI: 0.1%, 1.8%) Ab+ in March, to 6.2% (95%CI: 5.1%, 7.4%) PCR+ and 4.2% (95%CI: 3.3%, 5.3%) Ab+ in May. The highest SARS-CoV-2 prevalence was found in Hispanic individuals who made up 8.4% (95%CI: 7.4%, 9.4%) of individuals screened, but 35% (95%CI: 29%, 41%) of infections (PCR and/or Ab+). Demographic and clinical factors independently associated with acute infection included Hispanic ethnicity, loss of smell or taste, subjective fever, cough, muscle ache and fever. Factors independently associated with convalescent infection were Hispanic ethnicity and low oxygen saturation.

Conclusions

The burden of COVID-19 in Baltimore City increased dramatically over the 11-week study period and was disproportionately higher among Hispanic individuals. ED-based surveillance methods are important for identifying both acute and convalescent SARS-CoV-2 infections and provides important information regarding demographic and clinical correlates of disease in the local community.

Le texte complet de cet article est disponible en PDF.

Keywords : SARS-CoV-2 infection, Prevalence of SARS-CoV-2 antibody, Emergency department, Clinical correlates, Demographic correlates, Surveillance


Plan


© 2021  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 48

P. 261-268 - octobre 2021 Retour au numéro
Article précédent Article précédent
  • Empiric aztreonam is associated with increased mortality compared to beta-lactams in septic shock
  • Rupal K. Jaffa, John Hammer, Leigh Ann Medaris, William E. Anderson, Alan C. Heffner, Kelly E. Pillinger
| Article suivant Article suivant
  • Evaluation of fixed versus variable dosing of 4-factor prothrombin complex concentrate for emergent warfarin reversal
  • Zachary Stoecker, Brandon Van Amber, Casey Woster, Kurt Isenberger, Marissa Peterson, Paula Rupp, Ella Chrenka, David Dries

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.